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testing after pulmonary vein isolation to check for dor-
mant conduction has already been demonstrated to result in 
higher ablation success rates, and Kumar et al. [4] should be 
credited for their excellent work in this field.
More recently, we reported the impact of pulmonary 
vein orientation on EAS ablation outcome [6]. Interest-
ingly, arrhythmia-free survival varied between 21 and 88 % 
depending on left upper Pulmonary vein (PV) orienta- 
tion. Furthermore, arrhythmia-free survival varied between 
21 and 86 % depending on left lower PV orientation and 
arrhythmia-free survival varied between 29 and 88 % 
depending on right lower PV orientation. However, no asso-
ciation was found between right upper PV orientation and 
AF-free survival after EAS PV isolation.
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The data reported in our manuscript [1] on the results on 
the endoscopically assisted system (EAS) in the ablation 
of atrial fibrillation (AF) are remarkably similar to the data 
reported by Kumar et al. [2] and in the current literature. 
Procedure duration is around 180 min, with a fluoroscopy 
time of around 30 min, although there appears to be a sig-
nificant learning curve [3]. Furthermore, the EAS features 
a favourable safety profile, which was also observed in the 
analysis by Kumar.
There appears to be a difference in success after about 
18 months follow-up between the two papers, namely 
58 % in our study population, and 81 % in the population 
studied by Kumar. However, the difference is not statisti-
cally significant (chi square, p= 0.074), which is probably 
caused by the limited sample size in both our study group 
(n= 50) and Kumar’s (n= 24). Moreover, there appear to 
be more patients in persistent AF in our analysis compared 
with Kumar’s (18 vs. 10 %) [4]. Of note, the success rate in 
our study is in line with previously published larger stud-
ies. Dukkipati et al. reported a 58.5 % success rate in 200 
patients after a single EAS ablation [5].
At Heart Rhythm 2014, the results of the ADVICE (ade-
nosine following pulmonary vein isolation to target dormant 
conduction elimination) trial were presented. This study 
showed that, in case of dormant conduction during adenos-
ine administration, additional ablations targeting the abla-
tion gaps resulted in an increased arrhythmia-free survival 
post-ablation. Although not yet widely applied, adenosine 
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